IMDX
Insight Molecular Diagnostics Inc.
4.00$
+1.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 24.0% | 20.7% | 9.2% | 13.3% | 6.8% | 33.5% | 60.1% | 53.1% | 48.7% | 59.4% | 75.5% | 69.8% | |
| 19.8% | 16.9% | 7.9% | 12.4% | 4.8% | 24.6% | 51.4% | 48.1% | 42.5% | 45.0% | 69.8% | 60.3% | |
| 20.4% | 17.4% | 7.9% | 12.4% | 4.8% | 24.6% | 51.4% | 48.1% | 42.5% | 45.0% | 69.8% | 60.3% | |
| 2.0% | 2.3% | 0.2% | 0.1% | 0.3% | 4.6% | 5.9% | 1.0% | 0.6% | 4.4% | 0.4% | 0.7% | |
| 0.2% | 0.2% | – | – | 0.3% | 1.2% | 0.8% | 1.4% | 1.1% | 1.7% | 0.9% | 0.7% | |
| 64.7% | 69.4% | 79.7% | 75.7% | 80.5% | 41.6% | 24.2% | 28.9% | 33.2% | – | – | – | |
| 44.8% | 54.0% | 76.2% | 69.6% | 86.2% | 135.0% | 83.1% | 97.8% | 120.9% | 222.2% | 126.4% | 172.3% | |
| 8.8% | 9.8% | 11.7% | 9.6% | 12.9% | 20.7% | 16.0% | 13.2% | 17.4% | 46.9% | 29.7% | 34.9% | |
| 0.8% | 0.9% | 1.2% | 1.4% | 1.8% | 3.7% | 2.3% | 3.0% | 3.6% | 7.0% | 4.4% | 5.8% | |
| 1.0% | 1.4% | 1.3% | 1.4% | 1.2% | 6.5% | 3.8% | 2.5% | 2.4% | 9.9% | 4.0% | 6.4% | |
| 55.2% | 46.0% | 23.8% | 30.4% | 13.8% | -35.0% | 16.9% | 2.2% | -20.9% | -122.2% | -26.4% | -72.3% | |
| -303.8% | -334.0% | -421.3% | -406.2% | -451.5% | -999.2% | -591.8% | -726.4% | -859.9% | -1,556.0% | -1,001.9% | -1,414.0% | |
| 9.2% | 10.1% | 11.6% | 17.2% | 19.5% | 49.5% | 42.6% | 63.4% | 72.9% | 118.3% | 85.4% | 124.8% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.